We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Innovative Nanotechnology for Cancer Diagnostics

Life In Science   Feb 15, 2017 | By Anna MacDonald, Editor for Technology Networks

 
Innovative Nanotechnology for Cancer Diagnostics

Anna Macdonald

Science Writer

 
 
 

RELATED LIFE IN SCIENCE

Developing FTICR Mass Spectrometry Instruments with Unique Capabilities

Life In Science

Here Prof. Peter B. O'Connor, University of Warwick, touches on the adaptability of mass spectrometry, enabling researchers to study cancer, neurological disease, petroleum, and biopharmaceuticals.

READ MORE

Novel Technology Unlocks the Power of Positron Emission Tomography, Improving Disease Diagnostics

Life In Science

We recently spoke to Anton Toutov, Co-Founder and CSO at Fuzionaire, to learn how their radiolabeling platform can be used to improve disease diagnoses and drug discovery efforts. Anton touches on his professional background, his research on catalysis at Caltech, and how the discovery of a fundamentally new way to make and break molecular bonds can be applied to the diagnostics field.

READ MORE

Transforming Drug Discovery by Accelerating the Development of More Effective Therapies

Life In Science

John Baldoni currently heads up a drug discovery unit at GlaxoSmithKline. Since joining GSK in 1989, John has held numerous positions within the company and
has led many significant cross-functional strategic initiatives. The recently established Accelerating Therapeutics for Opportunities in Medicine (ATOM) consortium, was conceived by John, with a mission “to accelerate the development of more effective therapies for patients”

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE